October 11, 2016
October 11, 2016 —
A surgical team at UC San Diego Health has completed the first series of operations with a novel surgical system that can remove a diseased gallbladder through a single incision hidden in the belly button.
October 11, 2016
October 11, 2016 —
Professor of Cellular and Molecular Medicine Pradipta Ghosh, second guest in the series, will address “The Herculean Task of Killing Cancer Cells: Spare the Heads of Hydra; Strike the Heart,” at 4 p.m. on Tuesday, October 18, in the Roth Auditorium at the Sanford Consortium for Regenerative Medicine.
October 4, 2016
October 4, 2016 —
Physician-scientists with Moores Cancer Center at UC San Diego Health have been leading the way in pancreatic cancer care by investigating new therapies as well as offering innovative clinical trials and the latest treatments with a personalized medicine approach. This expertise led to the selection of Moores Cancer Center as one of 12 clinical trial sites for the Pancreatic Cancer Action Network’s newly created Precision Promise, the first large-scale precision medicine trial network designed to transform outcomes for patients with pancreatic cancer.
October 4, 2016
October 4, 2016 —
Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitize certain cancer cells to radiation therapy that may improve tumor control and reduce treatment-related side effects.
October 3, 2016
October 3, 2016 —
Researchers at University of California San Diego School of Medicine discovered a pattern of microbes indicative of IBD in dogs. With more than 90 percent accuracy, the team used that information to predict which dogs had IBD. However, they also determined that the gut microbiomes of dogs and humans are not similar enough to use dogs as animal models for humans with this disease. The study is published October 3 in Nature Microbiology.
October 3, 2016
October 3, 2016 —
Sports journalist and University of California San Diego alumnus Mark Johnson will take guests inside the metaphorical locker room to share the real dope on doping in professional sports, the focus of his new book, published in July 2016.
October 2, 2016
October 2, 2016 —
Approximately 20 percent of all human cancers have mutations in a gene called KRAS. KRAS-mutant cancers are among the most difficult to treat, with poor survival and resistance to chemotherapy. Researchers at University of California San Diego School of Medicine and Moores Cancer Center used microRNAs to systematically inhibit thousands of other genes to find combinations that are specifically lethal to cancer cells driven by a KRAS mutation.
September 27, 2016
September 27, 2016 —
The Howard Hughes Medical Institute (HHMI), the Simons Foundation and the Bill & Melinda Gates Foundation has named Samara Reck-Peterson, PhD, an HHMI-Simons Faculty Scholar. Reck-Peterson, a professor in the Department of Cellular and Molecular Medicine and Division of Biological Sciences at University of California San Diego, will receive a total of $1.5 million over five years in support of her studies on cargo transport within cells.
September 27, 2016
September 27, 2016 —
Biocom has announced the winners of its inaugural Life Science Catalyst Awards, presented in conjunction with the San Diego Venture Group, and UC San Diego-related innovators are prominent among the awardees.
September 27, 2016
September 27, 2016 —
The underlying cause of male infertility is unknown for 30 percent of cases. In a pair of new studies, researchers at University of California San Diego School of Medicine determined that the reproductive homeobox (RHOX) family of transcription factors — regulatory proteins that activate some genes and inactivate others — drive the development of stem cells in the testes in mice. The investigators also linked RHOX gene mutations to male infertility in humans.
